Spero Therapeutics | ARS:年度报告
04/16 16:21 (美东)
Spero Therapeutics | DEFA14A:其他
04/16 16:21 (美东)
Spero Therapeutics | DEF 14A:股东委托书决议
04/16 16:17 (美东)
Spero Therapeutics | 8-K:重大事件
03/29 16:17 (美东)
Spero Therapeutics | EFFECT:其他
03/25 06:03 (美东)
Spero Therapeutics | CORRESP:信函
03/20 13:56 (美东)
Spero Therapeutics | UPLOAD:其他
03/20 13:56 (美东)
Spero Therapeutics | S-3:特定交易注册声明
03/15 16:42 (美东)
Spero Therapeutics | S-8:员工福利计划证券登记
03/15 16:24 (美东)
Spero Therapeutics | 10-K:年度报表
03/13 16:15 (美东)
Spero Therapeutics | 8-K:Spero Therapeutics公布2023年第四季度和全年经营业绩并提供业务最新情况
03/13 16:11 (美东)
Spero Therapeutics | SC 13G:超过5%持股股东披露文件-Anson Funds Management LP(8.1%),Anson Management GP LLC(8.1%)等
02/14 17:38 (美东)
Spero Therapeutics | 8-K:重大事件
02/09 16:12 (美东)
Spero Therapeutics | 4:持股变动声明-高管 Keutzer Timothy
02/05 20:59 (美东)
Spero Therapeutics | 4:持股变动声明-董事 Mahadevia Ankit
02/05 20:54 (美东)
Spero Therapeutics | 4:持股变动声明-高管 JOSEPH TAMARA L
02/05 20:54 (美东)
Spero Therapeutics | 4:持股变动声明-高管 HAMED KAMAL
02/05 20:49 (美东)
Spero Therapeutics | 4:持股变动声明-高管 Rajavelu Esther
02/05 20:49 (美东)
Spero Therapeutics | 4:持股变动声明-高管 Shukla Sath
02/05 20:44 (美东)
Spero Therapeutics | 144:拟议出售证券
02/05 16:54 (美东)
暂无数据
暂无数据